SK Life Science
NJ - ParamusBiotechnology
Focus: SK Life Science is a specialty pharmaceutical company focused on small-molecule CNS therapies, built around its peak-stage epilepsy asset XCOPRI (cenobamate). Currently a publicly traded, single-product-dependent entity headquartered in Paramus, NJ.
Profile data last refreshed 4h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
15
Should You Work at SK Life Science?
AI assessmentSuitable for specialists seeking focused CNS expertise and product-driven impact in a capital-efficient, publicly traded specialty shop—but limited scale and single-product revenue concentration carry material risk.
Why Work Here
- XCOPRI is at peak lifecycle with $113M in Part D spending and LOE not until 2039, providing a stable revenue foundation for a small, focused team.
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Late-stage
14 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$113M Part DStable
Peak12.6yr
Flagship product driving 100% of company revenue; sodium channel antagonist with extended LOE through mid-2039.
Help build intelligence for SK Life Science
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.